Journal Watch
-
Surgery to fix PD catheters in place is safe, effective
PD catheters that move around in the belly can be painful and may stop working. Korean doctors compared 22 PD catheters placed by a laparoscopic technique that fixed them in place to 32 placed by open surgery. The age and sex of both groups was the same, and the fixing technique took longer to do. But, 29 months later, the fixed catheters were much less likely to move (13.6% vs. 65.6%). Both techniques had the same catheter and patient survival.
Read the abstract » | (added 2013-01-25)
Tags:
-
What does glucose in PD fluid have to do with artery calcification?
Quite a bit, it appears. Among 50 people doing PD who did not have diabetes, about half had coronary artery calcification. Those who used more higher glucose PD fluids were more likely to have the problem, as were men with a history of heart disease, and those who did not get enough PD.
Read the abstract » | (added 2013-01-25)
Tags:
-
Phosphate is a blood vessel toxin
High levels of phosphorus in the blood is linked with blood vessel calcification, thickened blood vessel walls, arterial stiffness, and heart damage—and may even cause premature aging.
Read the abstract » | (added 2012-12-19)
Tags: Chronic kidney disease
-
HbA1c levels do not predict survival in PD patients with diabetes
Researchers seeking a hemoglobin A1c target for PD patients with diabetes were not able to find any change in survival among 91 patients whose A1c levels were <6.5%, 6.5–8%, or >8%.
Read the abstract » | (added 2012-12-19)
Tags:
-
Community house home hemodialysis in Australia and New Zealand
Not everyone who wants to dialyze at home is able to. In Australia and New Zealand unstaffed, non-medical community homes fill a gap to make "home" treatments possible. This observational study compared mortality among 113 community home dialyzers to 5,591 people on PD, 1,532 on home HD, and 5,647 on in-center HD. Community house HD was safe and effective.
Read the abstract » | (added 2012-12-19)
Tags:
-
Modality choice is a factor in AV fistula creation
Canadian researchers compared the predialysis modality preferences of 508 people to their actual modality, and looked at their vascular accesses. The chance of having a fistula was much less in those who chose PD but started HD (39%), or who made no choice (50%), than in those who preferred HD and started on HD (79%).
Read the abstract » | (added 2012-12-19)
Tags:
-
Improve PD uptake by addressing misconceptions
In Singapore, interviews with predialysis patients and their families, people on dialysis, and health care professionals were done to explore how a treatment option choice is made. Fear of PD, daily commitment to PD, and misperceptions of PD were barriers that kept people from choosing the option. Patients were strongly influenced by other patients and wanted to hear what day-to-day life would be like before making a choice.
Read the abstract » | (added 2012-12-19)
Tags:
-
Neutral pH PD fluid protects peritoneal membranes
Standard PD fluid may have an acidic pH and contain high levels of glucose degradation products (GDPs). Japanese researchers followed 12 patients using standard fluid and 12 using a neutral pH fluid with low GDPs. The low GDP group had less membrane fibrosis, blood vessel sclerosis, and build up of AGEs, and had higher ultrafiltration volume than the high GDP group.
Read the abstract » | (added 2012-12-19)
Tags:
-
CAPD improved outcomes in hard to treat CHF
In a study in Spain, 28 people with advanced congestive heart failure were treated with PD, while 34 controls were not. Sixteen months later, those who did PD were 40% more likely to survive.
Read the abstract » | (added 2012-11-27)
Tags:
-
Biocompatible PD solution preserves residual kidney function
Researchers in Korea looked at the long-term impact of using Fresenius Balance® (FB) fluid vs. standard PD fluid. After 24 months, the GFR of patients using FB was twice that of those using standard fluid. Patients using FB also had better correction of metabolic acidosis, and higher levels of cancer fighting antigens.
Read the abstract » | (added 2012-11-27)
Tags: